ArticleCancer science2022

Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.

Nako Maishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.